Expression of Etk/Bmx Tyrosine Kinase in Intrahepatic Cholangiocarcinoma
β Scribed by Linlang Guo; Ying Guo; Sha Xiao
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 263 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Intrahepatic cholangiocarcinoma is a neoplasm arising in the liver, and its incidence is increasing in Japan as well as in Western countries. Prognosis of patients with this type of tumor remains unsatisfactory because no effective chemotherapeutic drugs are available, we have no sensitive tumor mar
Background and Objectives: This study was designed to identify a difference in immunostaining that might help to distinguish between primary and metastatic liver neoplasms. Methods: We examined immunohistochemical expression of cytokeratins (CKs) 7, 8, 19, and 20 in 12 intrahepatic cholangiocarcinom
## Abstract Cytoplasmic proteinβtyrosine kinases (PTKs) are enzymes involved in transducing a vast number of signals in metazoans. The importance of the Tec family of kinases was immediately recognized when, in 1993, mutations in the gene encoding Bruton's tyrosine kinase (Btk) were reported to cau
of their genes suggest that they have unique roles and distri-To date, seven apomucins have been characterized bution. [9][10][11][12][13][14][15][16][17][18] Changes in apomucin expression in carcinoma tisand their expression in malignant and premalignant lesues and their precursor lesions, as well